Neuraminidase-IN-19 (compound 5n) is an inhibitor (IC50: 0.13 μM) of neuraminidase with a thiophene ring (neuraminidase) and has anticancer activity.[17][1].

Neuraminidase-IN-20 (Compound 5i) is a potent inhibitor of mutant neuraminidase (NA) (H5N1-H274Y) (IC50 = 0.44 μM).Neuraminidase-IN-20 binds to the 430 cavity site of NA and disrupts the enzymatic activity of NA[1].

Neuraminidase, arthrobacter ureafaciens is an exosialidase which cleaves α-ketosidic linkage between the sialic (N-acetylneuraminic) acid and an adjacent sugar residue. Neuraminidase can facilitate virus release from infected cells[1].

NEURL1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEURL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEURL1B Human Pre-designed siRNA Set A contains three designed siRNAs for NEURL1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEURL2 Human Pre-designed siRNA Set A contains three designed siRNAs for NEURL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEURL3 Human Pre-designed siRNA Set A contains three designed siRNAs for NEURL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEURL4 Human Pre-designed siRNA Set A contains three designed siRNAs for NEURL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROD1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROD2 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROD4 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROD6 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROG1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROG2 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEUROG3 Human Pre-designed siRNA Set A contains three designed siRNAs for NEUROG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Neuromedin B-30 is the neuropeptide, which is orignally isolated from porcine brain and spinal cord, and may exhibit activity in stimulating smooth-muscle[1][2].

Neuromedin U-25 human is the active form of neuromedin U in human. Neuromedin U-25 human inhibits glucose-stimulated insulin secretion, which leads to early-onset obesity. Neuromedin U-25 serves as vasoconstrictor in human vascular beds[1][2].

Neuropeptide DF2 is a DRNFLRFamide neuropeptide orignally isolated from crayfish. which enhances transmitter release and stimulates the amplitude of excitatory post-synaptic potentials (EPSP) through the calcium/calmodulin-dependent protein kinase[1].

Neuropeptide K, human, porcine, rat exhibits bioactivity in gallbladder contraction, protein extravasation, hypotension and brcnchial smooth muscle spasm. Neuropeptide K, human, porcine, rat is concentrated in brain and acts as tachykinin neuromessenger[1].

Neurotransmitters are chemical messengers that allows a neuron’s electrical signal to pass to a postsynaptic neuron or effect target. Neurotransmitters include amino acids, monoamines, and peptides, while other neurotransmitters are composed of metabolites such as nitric oxide and carbon monoxide. The function of neurotransmitters is closely related to the disease of life, helping to regulate […]

Neutrophil elastase inhibitor 6 (compound 113) is an irreversible phosphonic-type inhibitor of human neutrophil elastase[1].

Nevirapine (Standard) is the analytical standard of Nevirapine. This product is intended for research and analytical applications. Nevirapine is a non-nucleoside inhibitor of HIV-1 reverse transcriptase used to treat and prevent HIV/AIDS; with a Ki of 270 μM[1].

NEXMIF Human Pre-designed siRNA Set A contains three designed siRNAs for NEXMIF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEXN Human Pre-designed siRNA Set A contains three designed siRNAs for NEXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NF-κB-IN-15 (compound 14r) is a potent NF-κB inhibitor. NF-κB-IN-15 decreases the NO levels and inhibits the release of IL-6, TNF-α, and IL-1β in LPS (HY-D1056) -induced cells. NF-κB-IN-15 inhibits LPS-induced phosphorylation of p65 and degradation of IκBα. NF-κB-IN-15 shows anti-inflammatory activity has the potential for the research of acute lung injury (ALI)[1].

NF-κB-IN-16 (compound 9) is a complex (Pt(IV) complex) of NF-κB inhibitor and Cisplatin (HY-17394), which has high efficacy and low toxicity in anti-tumor activity. active. NF-κB-IN-16 can cause DNA damage, induce mitochondrial dysfunction, produce reactive oxygen species, and induce apoptosis through the mitochondrial pathway and endoplasmic reticulum stress. NF-κB-IN-16 potently inhibits the NF-κB/MAPK signaling pathway […]

NF1 Human Pre-designed siRNA Set A contains three designed siRNAs for NF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NF2 Human Pre-designed siRNA Set A contains three designed siRNAs for NF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFAM1 Human Pre-designed siRNA Set A contains three designed siRNAs for NFAM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFASC Human Pre-designed siRNA Set A contains three designed siRNAs for NFASC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFAT5 Human Pre-designed siRNA Set A contains three designed siRNAs for NFAT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFATC1 Human Pre-designed siRNA Set A contains three designed siRNAs for NFATC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFATC2 Human Pre-designed siRNA Set A contains three designed siRNAs for NFATC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFATC2IP Human Pre-designed siRNA Set A contains three designed siRNAs for NFATC2IP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFATC3 Human Pre-designed siRNA Set A contains three designed siRNAs for NFATC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NFATC4 Human Pre-designed siRNA Set A contains three designed siRNAs for NFATC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.